Aurobindo Pharma is a manufacturer of quetiapine fumarate 300 mg tablets, an extended-release formulation of the atypical antipsychotic medication quetiapine [1]. Quetiapine is used to treat schizophrenia and bipolar disorder [2].
When might Aurobindo's quetiapine face generic competition?
The patent expiry for quetiapine fumarate extended-release formulations can be complex and may involve multiple patents covering different aspects of the drug, such as composition of matter, formulation, and methods of use. For specific details on patent expiration dates relevant to quetiapine extended-release, resources like DrugPatentWatch.com may provide detailed information [3].
What is quetiapine used for?
Quetiapine is prescribed to manage symptoms of schizophrenia in adults and adolescents, and to treat manic episodes associated with bipolar I disorder in adults and children aged 10 years and older. It is also used to manage depressive episodes associated with bipolar II disorder in adults and adolescents [2].
How does quetiapine work?
Quetiapine is believed to work by affecting the activity of certain neurotransmitters in the brain, including dopamine and serotonin. By altering the balance of these chemicals, it helps to regulate mood and thought processes [2].
Are there other manufacturers of quetiapine?
Yes, quetiapine is available from multiple manufacturers in both immediate-release and extended-release formulations. Aurobindo Pharma is one of several generic pharmaceutical companies that produce quetiapine fumarate [1].
What are the potential side effects of quetiapine?
Common side effects of quetiapine can include drowsiness, dizziness, dry mouth, constipation, weight gain, and blurred vision. More serious side effects, though less common, may include increased risk of stroke in elderly patients with dementia-related psychosis, metabolic changes, and movement disorders [2].
What is the difference between immediate-release and extended-release quetiapine?
Immediate-release quetiapine is taken multiple times a day, while extended-release quetiapine is designed to release the medication slowly over a longer period, allowing for once-daily dosing. Extended-release formulations can help maintain more stable drug levels in the body [2].
What is the regulatory status of quetiapine?
Quetiapine fumarate is an approved medication by regulatory bodies such as the U.S. Food and Drug Administration (FDA) for its indicated uses. Generic versions must meet the same strict standards for safety and efficacy as the brand-name drug [2].
What is Aurobindo Pharma?
Aurobindo Pharma is an Indian multinational pharmaceutical company that develops, manufactures, and markets a wide range of generic medications, including active pharmaceutical ingredients (APIs) and finished dosage forms [1].
Sources:
[1] Aurobindo Pharma. https://www.aurobindo.com/
[2] National Institute of Mental Health. https://www.nimh.nih.gov/health/topics/schizophrenia
[3] DrugPatentWatch.com. https://drugpatentwatch.com/